James T. Forbes
- Molecular Biology top 10%
- Oncology top 5%
- Immunology top 10%
- Genetics top 10%
- Cancer Research top 10%
- Co-authors
- Carlos L. ArteagaJean F. SimpsonAnne E.G. LenferinkHirokazu KurokawaStephen D. HurdB M FendlyMark X. SliwkowskiPaul I. Pisacane
- Topics
- Monoclonal and Polyclonal Antibodies Research (8 papers)Rangeland and Wildlife Management (7 papers)Immune Cell Function and Interaction (6 papers)
- Cited by
- OncologyImmunologyMolecular Biology
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical InvestigationThe Journal of Immunology
- Partner nations
- United StatesCanadaRussia
In The Last Decade
James T. Forbes
40 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 102
- Molecular Biology 856
- Oncology 793
- Immunology 286
- Genetics 268
- Cancer Research 176
Countries citing papers authored by James T. Forbes
This map shows the geographic impact of James T. Forbes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James T. Forbes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James T. Forbes more than expected).
Fields of papers citing papers by James T. Forbes
This network shows the impact of papers produced by James T. Forbes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James T. Forbes. The network helps show where James T. Forbes may publish in the future.
Co-authorship network of co-authors of James T. Forbes
This figure shows the co-authorship network connecting the top 25 collaborators of James T. Forbes. A scholar is included among the top collaborators of James T. Forbes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James T. Forbes. James T. Forbes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 31 | |
| 2 | 31 | |
| 3 | 99 | |
| 4 | 11 | |
| 5 | 110 | |
| 6 | 131 | |
| 7 | Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells. | 310 |
| 8 | 112 | |
| 9 | 22 | |
| 10 | 289 | |
| 11 | 10 | |
| 12 | 40 | |
| 13 | 19 | |
| 14 | 7 | |
| 15 | 1 | |
| 16 | 1 | |
| 17 | Immunologic aspects of small cell carcinoma. | 7 |
| 18 | 3 | |
| 19 | 11 | |
| 20 | 8 |
About James T. Forbes
James T. Forbes is a scholar working on Immunology, Oncology and Environmental Chemistry, having authored 40 papers that have together received 1.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), Rangeland and Wildlife Management (7 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Oncology (793 citations), Immunology (286 citations) and Molecular Biology (856 citations). James T. Forbes has collaborated with scholars based in United States, Canada and Russia. Frequent co-authors include Carlos L. Arteaga, Jean F. Simpson, Anne E.G. Lenferink, Hirokazu Kurokawa, Stephen D. Hurd, B M Fendly, Mark X. Sliwkowski, Paul I. Pisacane, Teresa C. Dugger and Susan A. Halter. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.